Background Induction of superovulation with gonadotropins and intrauterine
insemination are frequently used to treat infertility. We conducted a large
, randomized, controlled clinical trial of these treatments.
Methods We studied 932 couples in which the woman had no identifiable infer
tility factor and the man had motile sperm. The couples were randomly assig
ned to receive intracervical insemination, intrauterine insemination, super
ovulation and intracervical insemination, or superovulation and intrauterin
e insemination. Treatment continued for four cycles unless pregnancy was ac
hieved.
Results The 231 couples in the group treated with superovulation and intrau
terine insemination had a higher rate of pregnancy (33 percent) than the 23
4 couples in the intrauterine-insemination group (18 percent), the 234 coup
les in the group treated with superovulation and intracervical insemination
(19 percent), or the 233 couples in the intracervical-insemination group (
10 percent). Stratified, discrete-time Cox proportional-hazards analysis sh
owed that the couples in the group treated with superovulation and intraute
rine insemination were 3.2 times as likely to become pregnant as those in t
he intracervical-insemination group (95 percent confidence interval, 2.0 to
5.3) and 1.7 times as likely as those in the intrauterine-insemination gro
up (95 percent confidence interval, 1.2 to 2.6). The couples in the intraut
erine-insemination group and in the group treated with superovulation and i
ntracervical insemination were nearly twice as likely to conceive as those
in the intracervical-insemination group.
Conclusions Among infertile couples, treatment with induction of superovula
tion and intrauterine insemination is three times as likely to result in pr
egnancy as is intracervical insemination and twice as likely to result in p
regnancy as is treatment with either superovulation and intracervical insem
ination or intrauterine insemination alone. (N Engl J Med 1999; 340:177-83.
) (C) 1999, Massachusetts Medical Society.